Good day, ladies and gentlemen, and welcome to the Third Quarter 2012 Smith & Wesson Holding Corporation Earnings Conference Call. My name is Tahesha, and I'll be your operator for today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. I would now like to turn the conference over to your host for today, Ms. Liz Sharp, Vice President of Investor Relations. Please proceed.

Thank you, and good afternoon. Our comments today may contain predictions, estimates and other forward-looking statements. Our use of words like anticipate, project, estimate, expect, intend and other similar expressions is intended to identify those forward-looking statements. Forward-looking statements also include statements regarding sales, margins, expenses and earnings for future periods, our product development and strategies and liquidity and anticipated cash needs and availability. Our forward-looking statements represent our current judgment about the future, and they are subject to various risks and uncertainties. Risk factors and other considerations that could cause our actual results to be materially different are described in our securities filings, including our Forms S-3, 8-K, 10-K and 10-Q. You can find those documents as well as a replay of this call on our website at smith-wesson.com. Today's call contains time-sensitive information that is accurate only as of this time, and we assume no obligation to update any forward-looking statements contained herein. Our actual results could differ materially from our statements today. Now, I will turn the call over to our President and CEO, James Debney.

Good afternoon. Thank you for joining us, and thank you for your interest in our company. With me on the call today is Jeff Buchanan, our Chief Financial Officer, who later on will provide a recap of our financial performance and an updated outlook. Our fiscal third quarter results delivered a material financial improvement and clearly demonstrates progress on a number of key strategic and operational initiatives. Here are some of the highlights. We exceeded the high end of our sales guidance, the results of an exceptional operational effort of the team in stretching the capacity of our existing lines a bit earlier than expected. We more than doubled our year-over-year backlog. And today, we raised our fiscal 2012 full-year revenue guidance. We materially improved gross margins, and we delivered positive net income from continuing operations versus a loss in the year-ago period. We launched Dimension, our latest Thompson/Center Arms bolt-action rifle, and 2 high-end M&P15 modern sporting rifles. We began manufacturing an exciting new handgun for the personal protection market. We'll launch that product at the NRA show in April. We completed our Thompson/Center Arms consolidation on time and on budget, which will improve both efficiencies and gross margins. And we sold our foundry business in New Hampshire and continue to market the real estate to a number of interested parties. I believe our results this quarter clearly demonstrated the very positive impact that we can generate by focusing intently on our firearms business. Our strategic and long-term objectives are as follows: focus on our core firearms business; deliver truly exceptional high-quality products; grow with the expanding market but more importantly, take market share; and continue improving our gross and operating margins. All of these objectives are designed to drive shareholder value. So with that, I'll ask Jeff to review our third quarter financial results.

Thanks, James. Revenue was $98.1 million, which was about $2 million above the high end of our guidance. This is an increase of $18.9 million or 23.8% over the prior year. The gross margins -- the third quarter gross margin was 30.6%, over 6 percentage points higher than the 24.5% reported last year. I would note that the year-ago quarter included costs related to our strategic price repositioning activities. Our gross margin was also helped by the increased sales volume, which improved overhead absorption. Cost savings efforts reduced promotion costs, the completion of the T/C move, and product mix also contributed to the improvement. With regard to our product mix, we frequently get questions from investors on our various product gross margins. We do not give out that detail because it is highly competitive in nature. But I can give you some general thoughts. Margins in our professional channel are roughly on par with margins in our consumer channel, while Walther product gross margins, were we largely act as a distributor, are much lower. International sales, which include both professional and consumer customers, tend to have the highest gross margins. Now turning to operating expense. Third quarter OpEx totaled $19.7 million or 20.1% of revenue versus $21.3 million or 26.9% of revenue last year. We were able to significantly lower our operating expense percentage by reducing our sales and marketing spend despite a nearly 24% increase in revenue. In addition, even though we had greater profit sharing and incentive expenses because of increased operating income, overall G&A costs were significantly down because of costs and saving efforts and because of the reduced legal expenses relating to the DOJ/SEC investigations. In fact, the net expense in the quarter relating to the DOJ/SEC investigation was a little over $300,000. And this was…

Thank you, Jeff. In terms of units, our growth for our third quarter came in at 20.4% excluding Walther products. That compares favorably to unit growth of adjusted mix or FBI background checks of 20% for the same period. Sales in our domestic consumer channel was strong at $86.8 million, which is 26% higher than last year. That growth was driven by increased consumer demand, especially for our M&P polymer pistols, our M&P modern sporting rifles and our BODYGUARD 380 pistol. In our professional channel, which includes international sales but also have an element of consumer sales, revenue was $10.4 million, an increase of 6% compared with the last year. Our sales to law enforcement and government agencies reflect our success with meeting the most demanding standards for performance, safety and durability. Our effort to satisfy these professional users translates to higher product performance for our consumer users as well. We believe this strategy supports growth in the consumer channel. Now moving to a discussion of products. New products are important to us, and we continue to maintain a robust new product pipeline. At SHOT Show in January, we launched 2 new M&P modern sporting rifles. We now have an even broader line in this very popular category, offering rifles ranging from the affordably priced entry level all the way up to the more expensive performance center models. Also at SHOT, we launched Dimension, the latest Thompson/Center Arms bolt-action hunting rifle with interchangeable components that deliver a range of calibers on a single platform. That's a highly competitive price point. And as I mentioned earlier, we will be launching an exciting new product at the NRA show in April. Today we initiated our launch process with the posting of a teaser video on our website. Our product strategy is to…

Thanks. For the fourth quarter, we expect sales of between $113 million and $118 million, with a gross profit margin between 32% and 33%. We have based that revenue estimate on our available capacity because given current market conditions, we believe we will sell nearly everything we can manufacture. We expect operating expenses that should be about $22 million, and we estimate the tax rate at approximately 41%. So based on that fourth quarter outlook, our sales guidance for the full year would rise -- that should be between $395 million and $400 million, which would represent growth in excess of 15%. The gross profit margin for the year would approach 30%. Operating expenses would be around 21%, and our tax rates would be around 41%. And lastly, we expect our share count for the fourth quarter and for the full fiscal year to be about 65 million shares. James?

Thanks, Jeff. I want to thank the entire Smith & Wesson team for delivering a great quarter. And that concludes our prepared remarks, so now let's open the call to questions from our analysts.

[Operator Instructions] Your first question comes from the line of Cai Von Rumohr.

Could you give us a little color on the split between handguns, Walther and sales in the quarter? I know we'll get it in the Q coming up.

Yes. Handguns were about $57 million, which was about 58% of the total. Walther was $7.7 million, which was just a little over 7%. Modern and sporting rifles were $20 million at around 20%. Hunting was $4 million at 4%, and then there was other at around 9%.

Got it. Okay. And so on the DOJ issue, given that the case has been dismissed against your employee, should we -- does it look like now that, that number is going to stay at that level, the $300k or possibly been received?

Yes. I think for the -- it's hard to actually figure out where this is going based on the recent dismissal of charges. So you can probably assume it would will be in this range, but it's hard to say because as you know, there is the recent dismissal of charges against the entire group, including our former employee.

Okay. Very good. And you have that impressive gross margin in the third quarter, and I know the demand was stronger than it normally is. But the fourth quarter, how come -- usually that you get that extra -- that very strong volume. I would've expected given that you did 30.6% that you might be even above 33%. Is that a cautious number or is there something else going on here in terms of mix or something like that?

As we are ramping, we're doing this mix of outsourcing and insourcing because the insourcing ramp, it takes a lot longer, and it basically changes this long-term strategy to do a little more outsourcing. So that is probably impacted a bit by some of the outsourcing costs.

You'll certainly see the outsourced components start to flow in more in the Q4.

Okay. So that should -- okay. And the outsourcing is, what, lower gross margin but lower op expense or maybe help me understand that a bit.

Yes, it's definitely lower capital expenditures. And then of course, when you're relying on products you typically make, then the person that is making it has to make a profit and so that results in a higher cost to us.

Yes. We look at the assets. Remember Cai, we're losing an absorption opportunity there as each manufactured component that we buy in and assemble into a finished product.

Okay. And it looks like your CapEx for the fourth quarter, is that a little lower than you had anticipated? Is there any slip there at all?

Yes, it is a little bit lower than expected. I wouldn't call it a slip. I'd call it planned deferral.

Because of?

Just because that's all we need right now. That's the best way to say it.

Yes. I mean, you've got back to what I was talking about in the scripts in terms of the level of activity in the operation at the moment. So if there's only so much we can handle, and we've got to be smart about that. We don't want to overheat.

Okay, good. And you continue to do extraordinarily well in terms of if cash flow is good. So and now that you've retired the debt as we go forward, your net-debt-to-cap is now at relatively relaxed levels and presumably going positive next year. Any thoughts about cash deployment?

Basically, we will -- as James talked about, we're going through trying to analyze basically where the market is going, the capital expenditures we think we're going to need. So I think that we would -- probably would wait until the fall or early spring next year, basically see what is happening with respect to our cash our future needs and make a decision at that time, whether we retire debt or repurchase shares or save cash for a rainy day.

Yes. And you've got to think about our strategic focus is our M&P platform, and we have to make sure that we're right behind that, and that is sufficiently resourced in terms of everything plus cash.

Your next question comes from the line of the Rommel Dionisio from Wedbush Securities.

Jeff, I wonder if you could just give us a little more perspective on the market share gains that you're seeing in handguns specifically. I understand obviously, new products are part of that. But especially in the time of lowering sales and marketing spending a little bit, could you just walk us through the granularity of this winning formula that you found upon in terms of how you're gaining so much share. You know frankly and the piece had been around for a few years now.

We don't really go the details of our share analysis. But what I can tell you is we maintained in the quarter our leadership position when you talk about both the Smith & Wesson and the Walther branded handguns that some we produce and some we buy and we sell. So we're certainly after the leadership position. Certainly, when you think about trends out there, the consumer carry personal protection trend is still exceptionally strong. As you know, we have a great portfolio of products that lends itself to growing there and meeting the needs of the consumer. And as I mentioned, we're about to launch a brand-new product at the NRA show as well, which is straight into the consumer carry personal protection market. So I think how I'd summarize everything is we are in a very, very strong position to continue to grow. And as I mentioned, M&P is the best -- one of the best products out there. The adoption rate by the professional community is great, and we're looking forward to leveraging that in the future into the consumer channel.

[Operator Instructions] Your next question comes from the line of Bret Jordan from Avondale Partners.

A couple of quick questions, and one of them on the backlog. If you look at the backlog and some of the units in it this year versus last year, has there been any meaningful change, seeing a pickup in the M&P modern sporting rifle that drives either higher ASPs and any change in the margin in that backlog year-over-year?

We never go into the detail of what makes up our backlog by product, but as you've seen it, it continues to grow, which is a really good data point for us, helps us understand the mix of products that the market is demanding. As I said as well, we've been working with customers more into the future in terms of the next 12 months what their requirements will be. So if you like, there is a split now in terms of our backlog as for immediate shift versus a shift at some points in the future.

Okay. And I guess talking about the product launch coming up in mid-April at the NRA, this is a shield product. I guess it's called -- is that something -- it's clearly not in your backlog because you haven't shown it yet. But it sounds like you're manufacturing a certain amount of inventory for when the dealer orders come in. When did you start manufacturing that product? Is that something that's sort of in your fourth quarter projections as far as revenues or is it really going to trickle further out?

Yes. We started producing the product in the quarter in Q3, and we will be in a position of that launch where we do have inventory as we start to take orders.

Okay. And the one last question. On USR, just trying to get a feeling for where that is in its divestment. What's the sales trend on USR? You said it was operating cash-flow positive. Is it stabilized on a year-over-year revenue standpoint? If you could give us some kind of feeling for what it's tracking out on annualized sales?

Yes. I think it's stabilized and the revenue this year is -- it was $8 million in this quarter. The reason there was positive cash flow, it was cash flow that was produced out of working capital, reduced AR. We actually might spend a bit of working capital in Q4. But overall in the second half of the year, our goal was to get that cash flow neutral, and that's what we think it's going to be.

Okay. But $8 million in what would be a seasonally slow quarter for USR, I mean, we didn't have much winter impact. But as I recall, it was somewhat slower in the non-production months. Is it tracking to better than $30 million annualized?

It's roughly and we haven't really given a forecast on that. It was like $10 million a year ago on quarter, $8.4 million this quarter. So we're -- and we're currently in the sales process. We expect the sales process -- we start it around October. And that could take as long as a year but we are targeting the summertime hopefully to complete that transaction.

Okay. Then one last question. I guess on capacity utilization, are there any bottlenecks you've got at the New Hampshire consolidation into Springfield? Is there anything that as you've worked with that, that we've got any production limitations or is it relatively smooth sailing?

I mean, as a semi-completed the consolidation of Thompson Center into Springfield, so we're good. I mean that was done and in the quarter it started to prove itself, which we are very pleased to see, and we have a high level of confidence.

[Operator Instructions] And ladies and gentlemen, we have no more questions in the queue. I would now like to turn the conference over to the management for any closing remarks.

Thank you, operator, and thanks, everyone, for joining us today. I look forward to seeing those of you coming out for the NRA show in St. Louis in April. We'll also be attending the Roth Investor Conference in Laguna, California, on March 14, and hope to see some of you there. We look forward to speaking with you next quarter.

Ladies and gentlemen, that concludes today's conference. Thank you for your participation. You may now disconnect. Have a great day.